|
Market Cap (24-Jun) $27,342,400 (1,032nd) |
Close (30-Jun) $0.008 |
Volume (30-Jun) 285,280 |
Shortsold (12-Dec) 6,497 (0.00%) (681st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.09 |
EX1 released this announcement to the ASX on 30 August 2021, 8:28. The announcement is not marked as price sensitive, and is 34 page(s) in length and 551.48kb in size.
You can view all announcements from EX1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, EX1 was 0.073% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 681st as of the latest reported data (12 December 2022).
| Other Recent Announcements from EX1 | |
|---|---|
| Initial Director's Interest Notice - MD | 22 June 2023, 11:52 |
| Change of Director's Interest Notice - CB | 22 June 2023, 11:51 |
| Final Director's Interest Notice - JW | 22 June 2023, 11:50 |
| Appendix 4G and Corporate Governance Statement | 30 August 2021, 8:28 |
| FY2021 Appendix 4E and Annual Report | 30 August 2021, 8:17 |
| Investor Webinar Presentation | 26 August 2021, 10:07 |
| Investor Webinar Presentation | 20 August 2021, 8:06 |
You must be logged in to post a reply.
Exopharm 